These systems are expected to help minimise vaccine wastage, reduce dosage errors and impact public health by enabling therapy compliance for patients
Two new prefilled drug delivery devices – one for chronic diseases and another for vaccination were introduced at Technovation 2015 by BD Medical – Pharmaceutical Systems. BD Neopak is a single-dose, ready-to-use glass prefillable syringe system. It is an advanced version of normal prefillable syringe, particularly suitable for biotech drugs, that are more sensitive in nature and require delivery devices ensuring virtually no interaction and aggregation with the drug. Reportedly, BD Neopak offers additional benefits of PFS such as lesser injection time, lesser errors, reduced contamination and much better productivity to patients and clinicians.
BD Uniject SCF is a single-use prefilled auto disable injection system that protects against inappropriate needle reuse. Being tamper proof, this system can be used even by healthcare workers, for greater coverage of outreach programmes such as mass immunisation. Both forms of drug delivery is expected to assist the process of administering pharma compounds to achieve desired effect far more quickly and effectively.
“In the current environment, patients demand higher quality and more reliability in injectable drug delivery systems. Therefore there is an urgent need to be able to collaborate with industry leaders and introduce cutting edge solutions that will greatly benefit Indian patients. BD as a technology and innovation driven organisation has been prudent to respond to evolving needs and provide great value to customers,” said Murli Sundrani, Business Director, BD Medical-Pharmaceutical Systems, BD India.
Comments are closed.